1. Home
  2. CING vs CNFR Comparison

CING vs CNFR Comparison

Compare CING & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • CNFR
  • Stock Information
  • Founded
  • CING 2012
  • CNFR 2009
  • Country
  • CING United States
  • CNFR United States
  • Employees
  • CING N/A
  • CNFR N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • CNFR Property-Casualty Insurers
  • Sector
  • CING Health Care
  • CNFR Finance
  • Exchange
  • CING Nasdaq
  • CNFR Nasdaq
  • Market Cap
  • CING 14.4M
  • CNFR 13.7M
  • IPO Year
  • CING 2021
  • CNFR 2015
  • Fundamental
  • Price
  • CING $4.27
  • CNFR $1.00
  • Analyst Decision
  • CING Strong Buy
  • CNFR
  • Analyst Count
  • CING 3
  • CNFR 0
  • Target Price
  • CING $16.00
  • CNFR N/A
  • AVG Volume (30 Days)
  • CING 118.1K
  • CNFR 4.2K
  • Earning Date
  • CING 03-31-2025
  • CNFR 04-03-2025
  • Dividend Yield
  • CING N/A
  • CNFR N/A
  • EPS Growth
  • CING N/A
  • CNFR N/A
  • EPS
  • CING N/A
  • CNFR 2.40
  • Revenue
  • CING N/A
  • CNFR $74,815,000.00
  • Revenue This Year
  • CING N/A
  • CNFR N/A
  • Revenue Next Year
  • CING N/A
  • CNFR $7.00
  • P/E Ratio
  • CING N/A
  • CNFR $0.41
  • Revenue Growth
  • CING N/A
  • CNFR N/A
  • 52 Week Low
  • CING $1.80
  • CNFR $0.65
  • 52 Week High
  • CING $20.83
  • CNFR $1.91
  • Technical
  • Relative Strength Index (RSI)
  • CING 42.05
  • CNFR 45.41
  • Support Level
  • CING $4.22
  • CNFR $0.96
  • Resistance Level
  • CING $4.58
  • CNFR $1.07
  • Average True Range (ATR)
  • CING 0.32
  • CNFR 0.04
  • MACD
  • CING -0.04
  • CNFR 0.01
  • Stochastic Oscillator
  • CING 12.64
  • CNFR 47.78

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.

Share on Social Networks: